Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group
(2024)
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group
Anno:
2024
Tipologia prodotto:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Lingua:
Inglese
Referee:
No
Nome rivista:
Allergy
ISSN Rivista:
0105-4538
N° Volume:
79
Numero o Fascicolo:
2
Intervallo pagine:
516-519
Parole chiave:
EGPA; T2 inflammation; benralizumab; dupilumab; eosinophilic granulomatosis with polyangiitis; mepolizumab; monoclonal antibodies; omalizumab; reslizumab; severe asthma
Breve descrizione dei contenuti:
EGPA in severe asthma patients
Id prodotto:
144424
Handle IRIS:
11562/1155736
ultima modifica:
1 maggio 2025
Citazione bibliografica:
Caminati, Marco; Fassio, Angelo; Alberici, Federico; Baldini, Chiara; Bello, Federica; Cameli, Paolo; Conticini, Edoardo; Cottin, Vincent; Crimi, Claudia; Dagna, Lorenzo; Delvino, Paolo; Deroux, Alban; Duran, Emine; Espigol‐frigole, Georgina; Karadag, Omer; Maule, Matteo; Moiseev, Sergey; Monti, Sara; Moroni, Luca; Padoan, Roberto; Pugnet, Gregory; Taille, Camille; Toniati, Paola; Vaglio, Augusto; Emmi, Giacomo,
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group«Allergy»
, vol. 79
, n. 2
, 2024
, pp. 516-519